amphotericin b
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
13 FDA-registered drug labelers
Astellas Pharma US, Inc.
Eugia US LLC
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Jubilant HollisterStier LLC
LETCO MEDICAL, LLC
Medisca Inc.
Mylan Institutional LLC
North China Pharmaceutical Huasheng Co. Ltd.
Professional Compounding Centers of America dba PCCA
Sun Pharmaceutical Industries, Inc.
Synbiotics Limited
Xellia Pharmaceuticals ApS
XGen Pharmaceuticals DJB, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Amphotericin B liposome
- •AmBisome
- •Amphotericin B
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Amphotericin B Injection
08/08/2025Chemical Identity
CAS1397-89-3
PubChem CID5280965
DTXSIDDTXSID9022601
FormulaC47H73NO17
Mol. Weight924.1 g/mol
SMILESCC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O
Data Sources
52809652026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/amphotericin b/cids/JSON
Archive: data/sources/pubchem_name/amphotericin b.json
CAS 1397-89-32026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 1397-89-32026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json